107 related articles for article (PubMed ID: 16336098)
1. Targeting the stromal fibroblasts: a novel approach to melanoma therapy.
Smalley KS; Lioni M; Herlyn M
Expert Rev Anticancer Ther; 2005 Dec; 5(6):1069-78. PubMed ID: 16336098
[TBL] [Abstract][Full Text] [Related]
2. Stromal reaction in cutaneous melanoma.
Labrousse AL; Ntayi C; Hornebeck W; Bernard P
Crit Rev Oncol Hematol; 2004 Mar; 49(3):269-75. PubMed ID: 15036266
[TBL] [Abstract][Full Text] [Related]
3. Prolonged survival of dendritic cell-vaccinated melanoma patients correlates with tumor-specific delayed type IV hypersensitivity response and reduction of tumor growth factor beta-expressing T cells.
López MN; Pereda C; Segal G; Muñoz L; Aguilera R; González FE; Escobar A; Ginesta A; Reyes D; González R; Mendoza-Naranjo A; Larrondo M; Compán A; Ferrada C; Salazar-Onfray F
J Clin Oncol; 2009 Feb; 27(6):945-52. PubMed ID: 19139436
[TBL] [Abstract][Full Text] [Related]
4. Is there a relationship between tissue inhibitor of metalloproteinase-1 and transforming growth factor-beta 1 with respect to malignant melanoma progression?
Kurdoglu M; Güllü IH; Akalin I
Med Hypotheses; 2001 Aug; 57(2):238-40. PubMed ID: 11461180
[TBL] [Abstract][Full Text] [Related]
5. Immunization against MUC18/MCAM, a novel antigen that drives melanoma invasion and metastasis.
Leslie MC; Zhao YJ; Lachman LB; Hwu P; Wu GJ; Bar-Eli M
Gene Ther; 2007 Feb; 14(4):316-23. PubMed ID: 17024104
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of tumor invasion depends on transdifferentiation of skin fibroblasts mediated by reactive oxygen species.
Cat B; Stuhlmann D; Steinbrenner H; Alili L; Holtkötter O; Sies H; Brenneisen P
J Cell Sci; 2006 Jul; 119(Pt 13):2727-38. PubMed ID: 16757516
[TBL] [Abstract][Full Text] [Related]
7. [Tumor-stroma interactions].
Billottet C; Jouanneau J
Bull Cancer; 2008 Jan; 95(1):51-6. PubMed ID: 18230570
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
9. Differential expression of matrix metalloproteinase-2 by fibroblasts in co-cultures with keratinocytes, basal cell carcinoma and melanoma.
Chen GS; Lu MP; Wu MT
J Dermatol; 2006 Sep; 33(9):609-15. PubMed ID: 16958805
[TBL] [Abstract][Full Text] [Related]
10. Local balance of transforming growth factor-beta1 secreted from cholangiocarcinoma cells and stromal-derived factor-1 secreted from stromal fibroblasts is a factor involved in invasion of cholangiocarcinoma.
Ohira S; Itatsu K; Sasaki M; Harada K; Sato Y; Zen Y; Ishikawa A; Oda K; Nagasaka T; Nimura Y; Nakanuma Y
Pathol Int; 2006 Jul; 56(7):381-9. PubMed ID: 16792547
[TBL] [Abstract][Full Text] [Related]
11. Reversion of tumor phenotype in surface transplants of skin SCC cells by scaffold-induced stroma modulation.
Willhauck MJ; Mirancea N; Vosseler S; Pavesio A; Boukamp P; Mueller MM; Fusenig NE; Stark HJ
Carcinogenesis; 2007 Mar; 28(3):595-610. PubMed ID: 17056607
[TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor-beta in cutaneous melanoma.
Javelaud D; Alexaki VI; Mauviel A
Pigment Cell Melanoma Res; 2008 Apr; 21(2):123-32. PubMed ID: 18426405
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of metastasis.
Nguyen TH
Clin Dermatol; 2004; 22(3):209-16. PubMed ID: 15262306
[TBL] [Abstract][Full Text] [Related]
14. Function and regulation of melanoma-stromal fibroblast interactions: when seeds meet soil.
Li G; Satyamoorthy K; Meier F; Berking C; Bogenrieder T; Herlyn M
Oncogene; 2003 May; 22(20):3162-71. PubMed ID: 12789292
[TBL] [Abstract][Full Text] [Related]
15. Ultrastructural studies of interactions of B16 melanoma cells and normal mouse skin fibroblasts in the three-dimensional collagen gels in vitro.
Mok CH; Chew EC; Riches DJ
Anticancer Res; 1986; 6(5):995-1004. PubMed ID: 3800340
[TBL] [Abstract][Full Text] [Related]
16. Modeling the cholesteatoma microenvironment: coculture of HaCaT keratinocytes with WS1 fibroblasts induces MMP-2 activation, invasive phenotype, and proteolysis of the extracellular matrix.
Laeeq S; Faust R
Laryngoscope; 2007 Feb; 117(2):313-8. PubMed ID: 17204986
[TBL] [Abstract][Full Text] [Related]
17. Phase II trial of a toll-like receptor 9-activating oligonucleotide in patients with metastatic melanoma.
Pashenkov M; Goëss G; Wagner C; Hörmann M; Jandl T; Moser A; Britten CM; Smolle J; Koller S; Mauch C; Tantcheva-Poor I; Grabbe S; Loquai C; Esser S; Franckson T; Schneeberger A; Haarmann C; Krieg AM; Stingl G; Wagner SN
J Clin Oncol; 2006 Dec; 24(36):5716-24. PubMed ID: 17179105
[TBL] [Abstract][Full Text] [Related]
18. [Tumor-stroma interactions: their role in the control of tumor cell invasion and metastasis].
Löffek S; Zigrino P; Mauch C
J Dtsch Dermatol Ges; 2006 Jun; 4(6):496-502; quiz 503. PubMed ID: 16734841
[No Abstract] [Full Text] [Related]
19. Stromal fibroblasts from basal cell carcinoma affect phenotype of normal keratinocytes.
Lacina L; Smetana K; Dvoránková B; Pytlík R; Kideryová L; Kucerová L; Plzáková Z; Stork J; Gabius HJ; André S
Br J Dermatol; 2007 May; 156(5):819-29. PubMed ID: 17263809
[TBL] [Abstract][Full Text] [Related]
20. Id2 suppression of p15 counters TGF-beta-mediated growth inhibition of melanoma cells.
Schlegel NC; Eichhoff OM; Hemmi S; Werner S; Dummer R; Hoek KS
Pigment Cell Melanoma Res; 2009 Aug; 22(4):445-53. PubMed ID: 19368689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
